-

06:50:16 AM

Latest AMGN Stock Market News

AMGN - AMGEN Inc.

09/22/21 4:00 PM

Nasdaq : AMGN

conferences

Amgen To Present At The 2021 Cantor Global Healthcare Conference

Amgen (NASDAQ:AMGN) will present at the Cantor Global Healthcare Conference at 2:00 p.m. ET on Monday, Sept. 27, 2021. Susan Sweeney, senior vice president, Global Marketing, Access and Capabilities and Peter H. Griffith, executive vice

RHEA-AI

neutral

09/22/21 9:00 AM

Nasdaq : AMGN

Amgen Releases 8th Edition of Biosimilar Trends Report

Amgen (NASDAQ: AMGN) today released the 8 th edition of the Biosimilar Trends Report, which examines the current state of the U.S. biosimilars marketplace across inflammation, oncology and nephrology categories, while a new feature considers how

RHEA-AI

very positive

09/20/21 7:02 PM

Nasdaq : AMGN

Amgen Wins Patent Case on Otezla® (apremilast)

Amgen today announced that the U.S. District Court for the District of New Jersey has upheld patents that protect Amgen's psoriasis therapy Otezla ® (apremilast) in a patent infringement lawsuit against Sandoz Inc. ("Sandoz") and Zydus

RHEA-AI

very negative

09/16/21 4:30 AM

Nasdaq : AMGN

LUMAKRAS™ (Sotorasib) Combined With Vectibix® (Panitumumab) Showed Encouraging Efficacy And Safety In Patients With KRAS G12C-Mutated Colorectal Cancer

Amgen (NASDAQ: AMGN) today announced the first combination study results from the Phase 1b /2 CodeBreaK 101 study, the most comprehensive global clinical development program in patients with KRAS G12C-mutated advanced colorectal cancer (CRC).

RHEA-AI

neutral

09/14/21 4:00 PM

Nasdaq : AMGN

Amgen And The Lundquist Institute Announce That Diadem Therapeuctics Will Receive The First Amgen Golden Ticket To BioLabs LA

Amgen (NASDAQ: AMGN) and The Lundquist Institute today announced that Diadem Biotherapeutics, Inc., has been awarded the first Amgen Golden Ticket in Southern California. Diadem will receive one year of lab space at BioLabs LA at The Lundquist

RHEA-AI

very positive

09/13/21 4:15 PM

Nasdaq : AMGN

conferences

Amgen To Present At The 2021 Bank of America Merrill Lynch Global Healthcare Conference

Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 11:45 a.m. ET on Friday, Sept. 17, 2021. Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the

RHEA-AI

neutral

09/13/21 4:00 PM

Nasdaq : AMGN

conferences

Amgen To Webcast Investor Call At ESMO 2021

Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with the European Society for Medical Oncology (ESMO) 2021 Congress. On Thursday, Sept. 16, 2021, at 8:30 a.m. ET, David M. Reese, M.D., executive vice

RHEA-AI

neutral

09/13/21 9:00 AM

Nasdaq, OTC : AMGN, KYKOY

Amgen To Showcase New Data From Inflammation Portfolio At EADV Virtual Congress 2021

Amgen (NASDAQ: AMGN) today announced that new data from its expanding inflammation pipeline and marketed portfolio will be presented at the European Academy of Dermatology and Venereology (EADV) 30 th Congress, which will take place virtually

RHEA-AI

neutral

09/13/21 9:00 AM

Nasdaq, OTC : AMGN, KNBWY, KYKOY

conferencesclinical trial

Kyowa Kirin to Present Atopic Dermatitis Clinical Data from KHK4083/AMG 451 Phase 2 Study at The European Academy of Dermatology and Venereology 30th Congress

Kyowa Kirin Co., Ltd., a global specialty pharmaceutical company creating innovative medical solutions utilizing the latest biotechnology, today announced detailed data from a Phase 2 study of KHK4083/AMG 451 will be highlighted in late-breaking oral presentation at the European Academy of Dermatology and Venereology 30 th Virtual Congress to be held...

RHEA-AI

neutral

09/09/21 5:00 PM

Nasdaq : AMGN

conferences

Amgen to Present at the 19th Annual Morgan Stanley Global Healthcare Conference

Amgen (NASDAQ:AMGN) will present at Morgan Stanley's 19th Annual Global Healthcare Conference at 2:45 p.m. ET on Tuesday, Sept. 14, 2021. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. Live audio

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 10 Next

AMGN Data:

IndustryBiological Product (except Diagnostic) Manufacturing
Websitewww.amgen.com
CeoRobert Bradway
Security nameAMGEN Inc.
Issue typecs
SectorManufacturing
Sic code2836
Employees24300
Tags
- Health Technology
- Biotechnology
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Address1 Amgen Center Dr
StateCalifornia
CityThousand Oaks
Zip91320-1799
CountryUS
Phone18054471000

AMGN Description:

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.